Drug FDA Class II Ongoing Foreign material
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Merck Sharp & Dohme LLC Published Dec 31, 2025
Risk level
Class IIMay cause a temporary or reversible health problem; slight chance of serious harm.
Severity score 60/100
What should you do?
- Check whether you have this product, using the lot codes, UPCs, and dates listed below.
- Do not eat, serve, or sell the affected product.
- Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
- Contact Merck Sharp & Dohme LLC or your place of purchase with questions, and see the source record below for full details.
Reason for recall
Presence of particulate matter: potential presence of metal particulates in the product.
Hazards
Metal Particulate · primary
Affected products (1)
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
EMEND · 3 - single dose kits
NDC: 0006-0461, 0006-0462, 0006-3862, 0006-0464, 0006-3066, 0006-0461-02, 0006-0461-01, 0006-0461-06, 0006-0461-12, 0006-0462-01, 0006-0462-06, 0006-3862-03, 0006-3862-13, 0006-0464-01, 0006-0464-10, 0006-0464-05, 0006-3066-01, 0006-3066-03
Code info: Lot #: Z014503, Exp 11/15/2027
Affected areas
Nationwide
Timeline
- InitiatedDec 12, 2025
- PublishedDec 31, 2025
- Recall number
- D-0241-2026
- Agency
- U.S. Food and Drug Administration
- Country
- US
FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.